State Board Of Administration Of Florida Retirement System Cytom X Therapeutics, Inc. Transaction History

State Board Of Administration Of Florida Retirement System

$51.5 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$1.53 - $2.89 $33,197 - $62,707	-21,698 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$3.87 - $7.39 $599 - $1,145	155 Added 0.72%	21,698 $94,000
Q2 2021 Aug 10, 2021	BUY	$6.33 - $9.91 $3,418 - $5,351	540 Added 2.57%	21,543 $136,000
Q2 2020 Aug 07, 2020	BUY	$7.4 - $14.64 $15,976 - $31,607	2,159 Added 11.46%	21,003 $175,000
Q1 2020 May 05, 2020	SELL	$3.61 - $8.6 $649 - $1,548	-180 Reduced 0.95%	18,844 $145,000
Q2 2019 Aug 05, 2019	BUY	$9.35 - $11.41 $29,172 - $35,599	3,120 Added 19.62%	19,024 $213,000
Q4 2018 Feb 01, 2019	BUY	$12.69 - $18.61 $31,445 - $46,115	2,478 Added 18.46%	15,904 $240,000
Q3 2018 Oct 31, 2018	BUY	$18.04 - $26.41 $2,345 - $3,433	130 Added 0.98%	13,426 $248,000
Q2 2018 Aug 06, 2018	BUY	$21.38 - $29.68 $12,614 - $17,511	590 Added 4.64%	13,296 $304,000
Q1 2018 May 04, 2018	BUY	$21.76 - $34.22 $61,798 - $97,184	2,840 Added 28.79%	12,706 $361,000
Q4 2017 Feb 01, 2018	BUY	$19.0 - $23.09 $187,454 - $227,805	9,866	9,866 $208,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.7M

Call Options Held

112K

Put Options Held

8.3K

Tang Capital Management LLC San Diego, CA

7.81M
Shares

$8.28 Million
0.79% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$5.54 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

5.16M
Shares

$5.47 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.81M
Shares

$5.1 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.1M
Shares

$3.29 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account